Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing

Since September 2010, over 10,000 patients have undergone preemptive, panel-based pharmacogenomic testing through the Vanderbilt Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment (PREDICT) program. Analysis of the genetic data from the first 9,589 individuals reveals the frequenc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Van Driest, Sara L., Shi, Yaping, Bowton, Erica A., Schildcrout, Jonathan S., Peterson, Josh F., Pulley, Jill, Denny, Josh C., Roden, Dan M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961508/
https://ncbi.nlm.nih.gov/pubmed/24253661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2013.229
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi